Company Filing History:
1 out of 8 
1 out of 15,528 
1 out of 267 
Years Active: 2025
Title: David James: Innovator in Hepatic Lipid Dysregulation Therapies
Introduction: David James is a notable inventor based in Clontarf, Australia, recognized for his significant contributions to medical research through his innovative patent. His work primarily focuses on addressing metabolic disorders related to lipid homeostasis, particularly fatty liver disease.
Latest Patents: David holds one patent titled "PSMD9 inhibitors for the treatment of hepatic lipid dysregulation." This patent pertains to the post-genomic identification of therapeutic targets and agents, specifically PSMD9 inhibitors, which are crucial in developing methods to prevent or treat metabolic disorders associated with lipid dysregulation.
Career Highlights: Throughout his career, David James has made substantial advancements in the field of metabolic research. He has worked at reputable institutions, including the Baker Heart and Diabetes Institute and the University of California. His dedication to understanding and treating metabolic disorders has propelled his work into the spotlight.
Collaborations: David has collaborated with esteemed professionals such as Anna Christine Drew and Brian Gary Drew. These partnerships have facilitated the progression of research and the exploration of innovative solutions in the realm of lipid dysregulation and metabolic disorders.
Conclusion: David James is an influential inventor whose work on PSMD9 inhibitors is paving the way for new therapeutic options for individuals suffering from metabolic disorders. His collaborations and research endeavors continue to contribute to advancements in medical science, showcasing the impact of innovative thinking in addressing complex health challenges.